Adrian Raiche, Ph.D. has been named director of Formulation Development at Coldstream Laboratories, Inc. In this position, Dr. Raiche will head the formulation development group at Coldstream and will oversee teams focusing on process and product development, lyophilization and scale-up activities for manufacturing in the company's sterile manufacturing facility.
Dr. Raiche brings to Coldstream expertise in numerous aspects of pharma development, particularly lyophilization and potent compound handling. Most recently, he served as manager of Pharmaceutical Development at Summit Biosciences contributing to formulation, analytical and process development of nasal spray products. Prior experience includes tenures at SiO2 Medical Products, Brookwood Pharmaceuticals and Bausch and Lomb.
"We are pleased with Dr. Raiche's addition to the Coldstream team," said Coldstream's president and chief executive officer, Eric Smart. "His knowledge of process and product development enhances Coldstream's focus on the development of parenterals, especially our emphasis on highly active compounds."